Literature DB >> 23290135

Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8(+) T cells.

Raul Vizcardo1, Kyoko Masuda, Daisuke Yamada, Tomokatsu Ikawa, Kanako Shimizu, Shin-Ichiro Fujii, Haruhiko Koseki, Hiroshi Kawamoto.   

Abstract

Antigen-specific T cells represent a potential therapeutic avenue for a variety of conditions, but current approaches for generating such cells for therapeutic purposes are limited. In this study, we established iPSCs from mature cytotoxic T cells specific for the melanoma epitope MART-1. When cocultured with OP9/DLL1 cells, these iPSCs efficiently generated TCRβ(+)CD4(+)CD8(+) double positive (DP) cells expressing a T cell receptor (TCR) specific for the MART-1 epitope. Stimulation of these DP cells with anti-CD3 antibody generated a large number of CD8(+) T cells, and more than 90% of the resulting cells were specific for the original MART-1 epitope. Stimulation of the CD8(+) T cells with MART-1 antigen-presenting cells led to the secretion of IFNγ, demonstrating their specific reactivity. The present study therefore illustrates an approach for cloning and expanding functional antigen-specific CD8(+) T cells that might be applicable in cell-based therapy of cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23290135     DOI: 10.1016/j.stem.2012.12.006

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  138 in total

Review 1.  Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.

Authors:  Igor I Slukvin
Journal:  Blood       Date:  2013-10-11       Impact factor: 22.113

2.  Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.

Authors:  Zhenya Ni; David A Knorr; Laura Bendzick; Jeremy Allred; Dan S Kaufman
Journal:  Stem Cells       Date:  2014-04       Impact factor: 6.277

3.  RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.

Authors:  Audrey N Jajosky; James E Coad; Jeffrey A Vos; Karen H Martin; Jamie R Senft; Sharon L Wenger; Laura F Gibson
Journal:  Stem Cells Transl Med       Date:  2014-05-22       Impact factor: 6.940

Review 4.  'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.

Authors:  Eric Tran; Paul F Robbins; Steven A Rosenberg
Journal:  Nat Immunol       Date:  2017-02-15       Impact factor: 25.606

5.  NOTCH Activation at the Hematovascular Mesoderm Stage Facilitates Efficient Generation of T Cells with High Proliferation Potential from Human Pluripotent Stem Cells.

Authors:  Akhilesh Kumar; Jeong Hee Lee; Kran Suknuntha; Saritha S D'Souza; Abir S Thakur; Igor I Slukvin
Journal:  J Immunol       Date:  2018-12-21       Impact factor: 5.422

6.  Activation of the Arterial Program Drives Development of Definitive Hemogenic Endothelium with Lymphoid Potential.

Authors:  Mi Ae Park; Akhilesh Kumar; Ho Sun Jung; Gene Uenishi; Oleg V Moskvin; James A Thomson; Igor I Slukvin
Journal:  Cell Rep       Date:  2018-05-22       Impact factor: 9.423

Review 7.  New cell sources for T cell engineering and adoptive immunotherapy.

Authors:  Maria Themeli; Isabelle Rivière; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

Review 8.  Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency.

Authors:  Lorenz Studer; Elsa Vera; Daniela Cornacchia
Journal:  Cell Stem Cell       Date:  2015-06-04       Impact factor: 24.633

Review 9.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

10.  Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory.

Authors:  Hidehito Saito; Keisuke Okita; Alfred E Chang; Fumito Ito
Journal:  Cancer Res       Date:  2016-04-12       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.